The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
Open accessAbstract
SUMMARY Glucocorticoid resistance is a major driver of therapeutic failure in T-cell acute lymphoblastic leukemia (T-ALL). Here we identify the AKT1 kinase as a major negative regulator of the NR3C1 glucocorticoid receptor protein activity driving glucocorticoid resistance in T-ALL. Mechanistically, AKT1 impairs glucocorticoid-induced gene expression by direct phosphorylation of NR3C1 at position S134 and blocking glucocorticoid-induced NR3C1 translocation to the nucleus. Moreover, we demonstrate that loss of PTEN and consequent AKT1 activation can effectively block glucocorticoid induced apoptosis and induce resistance to glucocorticoid therapy. Conversely, pharmacologic inhibition of AKT with MK2206 effectively restores glucocorticoid-induced NR3C1 translocation to the nucleus, increases the response of T-ALL cells to glucocorticoid therapy and effectively reverses glucocorticoid resistance in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)
Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H.-G., Tsang, B. K., & Cheng, J. Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312044200 · Cited by 422
RetractedAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)
Zimmermann, S., & Moelling, K. (1999) · Science · doi:10.1126/science.286.5445.1741 · Cited by 1,078
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Palomero, T., Sulis, M. L., Cortina, M., Real, P. J., Barnes, K., Ciofani, M., Caparros, E., Buteau, J., Brown, K., Perkins, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1636 · Cited by 877
Self-citationHirai, H., Sootome, H., Nakatsuru, Y., Miyama, K., Taguchi, S., Tsujioka, K., Ueno, Y., Hatch, H., Majumder, P. K., Pan, B.-S., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1012 · Cited by 860
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 842
Pten Dose Dictates Cancer Progression in the Prostate
Trotman, L. C., Niki, M., Dotan, Z. A., Koutcher, J. A., Di Cristofano, A., Xiao, A., Khoo, A. S., Roy-Burman, P., Greenberg, N. M., Dyke, T. V., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000059 · Cited by 676
Self-citationWei, G., Twomey, D., Lamb, J., Schlis, K., Agarwal, J., Stam, R. W., Opferman, J. T., Sallan, S. E., den Boer, M. L., Pieters, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.006 · Cited by 509
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C.-H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 500
D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., & Riccardi, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80398-2 · Cited by 444
Glucocorticoid use in acute lymphoblastic leukaemia
Inaba, H., & Pui, C.-H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70114-5 · Cited by 367
Dördelmann, M., Reiter, A., Borkhardt, A., Ludwig, W.-D., Götz, N., Viehmann, S., Gadner, H., Riehm, H., & Schrappe, M. (1999) · Blood · doi:10.1182/blood.v94.4.1209 · Cited by 341
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
Kharas, M. G., Okabe, R., Ganis, J. J., Gozo, M., Khandan, T., Paktinat, M., Gilliland, D. G., & Gritsman, K. (2010) · Blood · doi:10.1182/blood-2009-06-229443 · Cited by 272
Glucocorticoid receptor physiology
Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F., & DeFranco, D. B. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9059-8 · Cited by 235
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras–initiated leukemia
Chiang, M. Y., Xu, L., Shestova, O., Histen, G., L’Heureux, S., Romany, C., Childs, M. E., Gimotty, P. A., Aster, J. C., & Pear, W. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35090 · Cited by 235
Wang, Z., Malone, M. H., He, H., McColl, K. S., & Distelhorst, C. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301843200 · Cited by 222
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia
Klumper, E., Pieters, R., Veerman, A., Huismans, D., Loonen, A., Hahlen, K., Kaspers, G., van Wering, E., Hartmann, R., & Henze, G. (1995) · Blood · doi:10.1182/blood.v86.10.3861.bloodjournal86103861 · Cited by 217
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells
Schlossmacher, G., Stevens, A., & White, A. E. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0135 · Cited by 180
NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity
Armstrong, F., de la Grange, P. B., Gerby, B., Rouyez, M.-C., Calvo, J., Fontenay, M., Boissel, N., Dombret, H., Baruchel, A., Landman-Parker, J., et al. (2009) · Blood · doi:10.1182/blood-2008-02-138172 · Cited by 176
Ayroldi, E., Zollo, O., Bastianelli, A., Marchetti, C., Agostini, M., Di Virgilio, R., & Riccardi, C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30724 · Cited by 165
Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia
Schmidt, S. U., Rainer, J., Riml, S., Ploner, C., Jesacher, S., Achmüller, C., Presul, E., Skvortsov, S., Crazzolara, R., Fiegl, M., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2853 · Cited by 149
Hongo, T., Yajima, S., Sakurai, M., et al. (1997) · Blood · doi:10.1182/blood.v89.8.2959 · Cited by 140
Guo, K., McMinn, J. E., Ludwig, T. E., Yu, Y., Yang, G., Chen, L., Loh, D., Cai, L., Chua, S. C., & Zhang, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0261 · Cited by 140
Bad Can Act as a Key Regulator of T Cell Apoptosis and T Cell Development
Mok, C.-L., Gil‐Gómez, G., Williams, O., Coles, M. C., Taga, S., Tolaini, M., Norton, T., Kioussis, D., & Brady, H. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.575 · Cited by 111
Riccardi, C., Cifone, M. G., & Migliorati, G. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400609 · Cited by 100
Morishita, N., Tsukahara, H., Chayama, K., Ishida, T., Washio, K., Miyamura, T., Yamashita, N., Oda, M., & Morishima, T. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24034 · Cited by 79
Bandapalli, O. R., Zimmermann, M., Kox, C., Stanulla, M., Schrappe, M., Ludwig, W.-D., Koehler, R., Muckenthaler, M. U., & Kulozik, A. E. (2013) · Haematologica · doi:10.3324/haematol.2012.073585 · Cited by 78
Beesley, A. H., Firth, M. J., Ford, J., Weller, R. E., Freitas, J. R., Perera, K. U., & Kees, U. R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605072 · Cited by 74
Bornhauser, B. C., Bonapace, L., Lindholm, D., Maza, R. M., Cario, G., Schrappe, M., Niggli, F. K., Schäfer, B. W., & Bourquin, J. (2007) · Blood · doi:10.1182/blood-2006-12-060970 · Cited by 63
Geng, C.-D., Schwartz, J. R., & Vedeckis, W. V. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0157 · Cited by 42
Cited by
Alvarez, M. J., Shen, Y., Giorgi, F. M., Lachmann, A., Ding, B. B., Ye, B. H., & Califano, A. (2016) · Nature Genetics · doi:10.1038/ng.3593 · Cited by 966
“An increasing catalog of non-oncogene dependencies has emerged in recent years 5,18,20,21,38,39 , whose aberrant activity depends on indirect genetic alterations, such as those in upstream pathways and cognate binding proteins.”
BackgroundMethodSelf-citationThe Varied Roles of Notch in Cancer
Aster, J. C., Pear, W. S., & Blacklow, S. C. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100127 · Cited by 710
PTEN: Multiple Functions in Human Malignant Tumors
Milella, M., Falcone, I., Conciatori, F., Cesta Incani, U., Del Curatolo, A., Inzerilli, N., Nuzzo, C. M. A., Vaccaro, V., Vari, S., Cognetti, F., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00024 · Cited by 463
The genetics and mechanisms of T cell acute lymphoblastic leukaemia
Belver, L., & Ferrando, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.63 · Cited by 446
Self-citationPathway and network analysis of cancer genomes
the Mutation Consequences and Pathway Analysis working group of the International Cancer Genome Consortium (2015) · Nature Methods · doi:10.1038/nmeth.3440 · Cited by 325
Metadata
- Authors
- Piovan, E., Yu, J., Tosello, V., Herranz, D., Ambesi-Impiombato, A., Da Silva, A. C., Sanchez-Martin, M., Perez-Garcia, A., Rigo, I., Castillo, M., Indraccolo, S., Cross, J. R., de Stanchina, E., Paietta, E., Racevskis, J., Rowe, J. M., Tallman, M. S., Basso, G., Meijerink, J. P., Cordon-Cardo, C., Califano, A., & Ferrando, A. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 24
- Issue
- 6
- Pages
- 766-776
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2071268727
- Cited by
- 256
- References
- 32
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.